Race Oncology (ASX:RAC) has completed its Phase 1b/2 trial of bisantrene in combination with clofarabine and fludarabine for ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

About CRB-701 CRB-701 (SYS6002) is a next-generation antibody-drug-conjugate (ADC) targeting Nectin-4, that contains a site-specific, cleavable linker and a homogenous drug antibody ratio of 2, using ...

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has received a Notice of ...

Women, girls, and other vulnerable groups are more likely to be exposed to and impacted by toxic substances – including lead, ...

With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at Case Western Reserve ...

The cherry on the cake came when she returned to Trinidad and opened the Gabriela Gopaul Medical Aesthetic Clinic in South ...

With negotiations on the first batch of 10 medicines now complete, the response from some in industry appears to be one of ...

Exscientia researchers combined '565 with the BTK inhibitor zanubrutinib and observed deeper, more durable efficacy responses in xenograft models of B-cell malignancies, with long-lasting tumour ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

The parish is located along a heavily industrialized stretch of the Mississippi River between New Orleans and Baton Rouge, ...

Focus on handholding patients through the disease cycle, a large pipeline of 300-plus molecules put Zydus ahead of the rest.